Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.35074 | 53 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.30866 | 53 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.31393 | 53 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.21523 | 52 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.24746 | 53 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.39619 | 53 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.34356 | 52 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.28991 | 53 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.29454 | 53 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.26082 | 52 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.31081 | 54 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.30642 | 54 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.30109 | 53 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.30189 | 53 |